Chemotherapy (maintenance following combination)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Chemotherapy (maintenance following combination), covering 2024-08-20 to 2024-08-20. Get the full timeline:
Most recent: Clinical Trial Update: Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial [Phase 2]